CPP-109
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for CPP-109, covering 2018-01-19 to 2018-01-19. Get the full timeline:
Most recent: Clinical Trial Update: Proof-of-Concept Safety Study of CPP-109 (Vigabatrin) for Treatment Refractory Tourette's Disorder [Phase 1, Phase 2]